Researchers Identify Gene Mutation That Raises Risk Of Nerve Damage in Leukaemia Patients Using Vincristine

Important research from St. Jude Children’s Research Hospital regarding the use of the anti-cancer drug Vincristine, often used for treating Acute Lymphoblastic Leukaemia (ALL)   Researchers from St. Jude Children’s Research Hospital have identified the first genetic variation that is associated with increased risk and severity of peripheral neuropathy following treatment with a widely used anti-cancer drug. Investigators also […]

Read more